Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05270135 · ClinicalTrials.gov registry record · NA
ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT05270135 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 18 participants.
The verdict
NCT05270135, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Access to Syringes at Pharmacies (ASAP) is a refinement of an evidence-based, pharmacy intervention to increase pharmacy-based sales of syringes to PWID in order to reduce bloodborne illnesses among them.
Interventions
- BEHAVIORAL ASAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2023-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05270135
The ClinicalTrials.gov registry entry for NCT05270135 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ASAP is the first listed.
NCT05270135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05270135 about?
NCT05270135 is a clinical study titled "ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs". Access to Syringes at Pharmacies (ASAP) is a refinement of an evidence-based, pharmacy intervention to increase pharmacy-based sales of syringes to PWID in order to reduce bloodborne illnesses among them.
What is the current status of trial NCT05270135?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-12-01. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT05270135?
The interventions under investigation include: ASAP (BEHAVIORAL).
Who is sponsoring clinical trial NCT05270135?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.